1-(4-Bromophenyl)-4,5-diphenyl-2-(1 H -pyrrol-2-yl)-1 H -imidazole

IUCrData 2026 Open access

Read full text
Authors: Seeralan Nagaraj, Nagarajan Loganathan
DOI: 10.1107/s2414314626001070
Cited by: 0

Abstract

The title compound, C 25 H 18 BrN 3 , crystallizes in the triclinic P 1 space group. It is of interest with respect to anticancer activity, antibiotic, antibacterial and antifungal properties. The extended structure features N—H...N, C—H...N, C—H...π, N—H...π, C—H...Br and C—Br...π interactions.

Fields of Study & Subjects

Crystal structures of chemical compounds Crystallography and molecular interactions Synthesis and biological activity

Publication details

Journal / source
IUCrData
Volume
11
Issue
2
Pages
x260107–x260107
Publication date
3 February 2026
Language
EN